Hansen Sandra Maria, Koefoed-Nielsen Pernille, Clemmensen Tor Skibsted, Eiskjær Hans, Staunstrup Nicklas Heine
Department of Clinical Immunology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Clinical Immunology, Aarhus University Hospital, Denmark.
Hum Immunol. 2025 Jan;86(1):111189. doi: 10.1016/j.humimm.2024.111189. Epub 2024 Dec 5.
Genomic collision at the LIM and senescent cell antigen-like-containing domain protein 1 (LIMS1) locus between donor and heart recipient was examined for the association with diagnosis of acute cellular or antibody-mediated allograft rejection, ACR or ABMR, respectively. In this single center retrospective study, 129 heart transplanted patients and donors were genotyped for the LIMS1 rs893403 variant, where the G-allele is in almost complete linkage disequilibrium with a loss of function deletion. A total of 14 cases with genomic collision (recipient genotype GG and donor genotype AA/AG) were identified. After a median follow-up time of 723 days, the multivariate adjusted hazard ratio for ACR of 1.64 (95 % CI 0.66-4.1) indicated that genomic collision indeed was a risk factor, while the risk of ABMR was less affected by genotype. Although statistically not significant, due to low power, this study indicates that LIMS1 is a minor histocompatibility antigen in heart transplantation, associated with allograft rejection.
研究了供体与心脏受体之间在含LIM和衰老细胞抗原样结构域蛋白1(LIMS1)基因座处的基因组碰撞,分别与急性细胞性或抗体介导的同种异体移植排斥反应(ACR或ABMR)的诊断之间的关联。在这项单中心回顾性研究中,对129例心脏移植患者和供体进行了LIMS1 rs893403变体的基因分型,其中G等位基因几乎与功能缺失性缺失完全连锁不平衡。共鉴定出14例基因组碰撞病例(受体基因型为GG,供体基因型为AA/AG)。在中位随访时间723天后,ACR的多变量调整风险比为1.64(95%CI 0.66-4.1),表明基因组碰撞确实是一个危险因素,而ABMR的风险受基因型的影响较小。尽管由于检验效能低,在统计学上不显著,但本研究表明LIMS1是心脏移植中的一种次要组织相容性抗原,与同种异体移植排斥反应相关。